Table 2.
Variation in the ECM related gene expression between HPCs control and TGF-β1-treated HPCs in RT2 profiler PCR array.
| Group | Position | Gene bank | Symbol | Description | Upregulation or downregulation |
|---|---|---|---|---|---|
| HPC + TGF-β1 (12 h)/HPC | E7 | NM_000602 | SERPINE1 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 12.8 |
| C6 | NM_002205 | ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | −4.7 | |
|
| |||||
| HPC + TGF-β1 (48 h)/HPC | A10 | NM_000089 | COL1A2 | Collagen, type I, alpha 2 | 40.0 |
| D5 | NM_004994 | MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase) | 13.4 | |
| G8 | NM_004626 | WNT11 | Wingless-type MMTV integration site family, member 11 | 6.0 | |
| E7 | NM_000602 | SERPINE1 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | −5.1 | |